162 related articles for article (PubMed ID: 31365143)
1. The association between diabetes medication and weight change in a non-surgical weight management intervention: an intervention cohort study.
Aldekhail NM; Morrison DS; Khojah H; Sloan B; McLoone P; MacNaughton S; Shearer R; Logue J
Diabet Med; 2020 Feb; 37(2):248-255. PubMed ID: 31365143
[TBL] [Abstract][Full Text] [Related]
2. Body Weight Considerations in the Management of Type 2 Diabetes.
Apovian CM; Okemah J; O'Neil PM
Adv Ther; 2019 Jan; 36(1):44-58. PubMed ID: 30465123
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
[TBL] [Abstract][Full Text] [Related]
4. Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet.
Bachmann KN; Roumie CL; Wiese AD; Grijalva CG; Buse JB; Bradford R; Zalimeni EO; Knoepp P; Dard S; Morris HL; Donahoo WT; Fanous N; Fonseca V; Katalenich B; Choi S; Louzao D; O'Brien E; Cook MM; Rothman RL; Chakkalakal RJ
Pharmacol Res Perspect; 2020 Oct; 8(5):e00637. PubMed ID: 32881317
[TBL] [Abstract][Full Text] [Related]
5. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
[TBL] [Abstract][Full Text] [Related]
6. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
7. Diabetes medications and body weight.
Mitri J; Hamdy O
Expert Opin Drug Saf; 2009 Sep; 8(5):573-84. PubMed ID: 19538102
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
[TBL] [Abstract][Full Text] [Related]
9. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
10. Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study.
Seong JM; Choi NK; Shin JY; Chang Y; Kim YJ; Lee J; Kim JY; Park BJ
PLoS One; 2015; 10(5):e0124287. PubMed ID: 25992614
[TBL] [Abstract][Full Text] [Related]
11. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
12. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.
Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A
Diabetes Res Clin Pract; 2020 Apr; 162():108090. PubMed ID: 32088311
[TBL] [Abstract][Full Text] [Related]
13. What to add in with metformin in type 2 diabetes?
Petrie JR; Adler A; Vella S
QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
[TBL] [Abstract][Full Text] [Related]
14. Which oral agent to use when metformin is no longer effective?
Bannon M
QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
[No Abstract] [Full Text] [Related]
15. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019.
Lee KA; Jin HY; Kim YJ; Im YJ; Kim EY; Park TS
J Korean Med Sci; 2021 Sep; 36(36):e230. PubMed ID: 34519186
[TBL] [Abstract][Full Text] [Related]
16. More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
Dankner R; Roth J
Diabet Med; 2020 Feb; 37(2):194-202. PubMed ID: 31769894
[TBL] [Abstract][Full Text] [Related]
17. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
[TBL] [Abstract][Full Text] [Related]
18. Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 years.
Botha S; Forde L; MacNaughton S; Shearer R; Lindsay R; Sattar N; Morrison D; Welsh P; Logue J
Diabetes Obes Metab; 2018 Apr; 20(4):879-888. PubMed ID: 29178635
[TBL] [Abstract][Full Text] [Related]
19. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
